Browsing by Author Foroni, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
1-Feb-2015A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCRWhite, H; Deprez, L; Corbisier, P; Hall, V; Lin, F, et al
22-Jan-2019Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?Gall, TMH; Gerrard, G; Frampton, AE; Castellano, L; Ahmad, R, et al
28-Jul-2016Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemiaClaudiani, S; Apperley, JF; Deplano, S; Khorashad, J; Foroni, L, et al
26-May-2017De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trialClark, RE; Polydoros, F; Apperley, JF; Milojkovic, D; Pocock, C, et al
1-Jul-2019De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trialClark, RE; Polydoros, F; Apperley, JF; Milojkovic, D; Rothwell, K, et al
1-Jun-2016DE-ESCALATION OF TYROSINE KINASE INHIBITOR THERAPY IS SAFE IN CHRONIC MYELOID LEUKAEMIA IN DURABLE MOLECULAR RESPONSE (>= MR3 FOR >= 12 MONTHS): INITIAL RESULTS IN THE BRITISH DESTINY STUDYClark, R; Polydoros, F; Apperley, J; Pocock, C; Smith, G, et al
3-Dec-2015DNA Methylation Profiling of Sorted Peripheral Blood Cells Using Microarray and Next Generation Sequencing Reveals Distinct Molecular Signatures in the Polymorphonuclear and Mononuclear Cells of Patients with Essential Thrombocythemia, Polycythemia Vera and Primary MyelofibrosisWong, CL; Ma, B; Adamowicz-Brice, M; Gerrard, G; Norziha, ZA, et al
11-May-2017E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in persons with chronic myeloid leukemia after stopping tyrosine kinase-inhibitor therapy.Claudiani, S; Apperley, J; Gale, RP; Clark, R; Szydlo, R, et al
3-Dec-2015Gene expression profiling of sorted peripheral blood cells using microarray and next generation sequencing reveals distinct molecular signatures in the polymorphonuclear and mononuclear cells of patients with polycythemia vera and primary myelofibrosisWong, CL; Ma, B; Gerrard, G; Adamowicz-Brice, M; Norziha, ZA, et al
27-Feb-2015Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaCross, NCP; White, HE; Colomer, D; Ehrencrona, H; Foroni, L, et al
14-Feb-2017Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.Alikian, M; Gale, RP; Apperley, JF; Foroni, L
Nov-2019MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemiaClaudiani, S; Gatenby, A; Szydlo, R; Nesr, G; Shacham Abulafia, A, et al
1-Jun-2016PRESENCE OF SOMATIC AND GERMLINE MUTATIONS IN EPIGENETIC MODIFIERS IN CML-CPNteliopoulos, G; Bazeos, A; Gerrard, G; Alikian, M; Foong, HE, et al
27-Jan-2017RT-qPCR and RT-Digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemiaAlikian, M; Whale, AS; Akiki, S; Piechocki, K; Torrado, C, et al
Dec-2019Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitorsNteliopoulos, G; Bazeos, A; Claudiani, S; Gerrard, G; Curry, E, et al
1-Apr-2019Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genesWang, J; Gerrard, G; Poskitt, B; Dawson, K; Trivedi, P, et al
3-Dec-2015Targeted sequencing of sorted peripheral blood cells reveals novel germline and somatic variants in the polymorphonuclear and mononuclear cells of patients with essential thrombocythemia, polycythemia vera and primary myelofibrosisWong, CL; Gerrard, G; Adamowicz-Brice, M; Norziha, ZA; Tumian, NR, et al
1-May-2019The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewBaccarani, M; Castagnetti, F; Gugliotta, G; Rosti, G; Soverini, S, et al
8-Feb-2016The status of epidermal growth factor receptor in borderline ovarian tumoursShoweil, R; Romano, C; Valganon, M; Lambros, M; Trivedi, P, et al